SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-146073
Filing Date
2023-05-16
Accepted
2023-05-16 16:03:07
Documents
13
Period of Report
2023-05-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d420969d8k.htm   iXBRL 8-K 35187
  Complete submission text file 0001193125-23-146073.txt   192895

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20230516.xsd EX-101.SCH 3878
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20230516_def.xml EX-101.DEF 13656
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20230516_lab.xml EX-101.LAB 22575
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20230516_pre.xml EX-101.PRE 14624
7 EXTRACTED XBRL INSTANCE DOCUMENT d420969d8k_htm.xml XML 5303
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 23927396
SIC: 2834 Pharmaceutical Preparations